Research and Markets: MediPoint: Drug-Eluting Balloons - Asia-Pacific Analysis and Market Forecasts to 2018

DUBLIN--(BUSINESSWIRE)-- Research and Markets (http://www.researchandmarkets.com/research/69hmld/medipoint) has announced the addition of the "MediPoint: Drug-Eluting Balloons - APAC Analysis and Market Forecasts" report to their offering.

The report is an essential source of information and analysis on the drug-eluting balloons (DEB) market in Asia-Pacific (APAC). The report provides in-depth insight into the use of DEB for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chronic total occlusions, acute myocardial infarction and lesions in diabetics.

The DEB market in three APAC countries including Japan, China and India was assessed to identify and determine whether the current unmet needs are addressed, understand the challenges of DEB angioplasty and evaluate the current and future adoption of DEB for select coronary and peripheral indications. The APAC sales expectations are discussed through careful analysis of adoption patterns of using these DEB.

Clients can use this report to better understand the scope of this technology and for strategic planning to explore opportunities in this dynamic market. The report also provides insights into the competitive landscape, the marketed and pipeline DEB products, the current and emerging players and comparative market analysis of different types of interventional techniques used to treat coronary and peripheral artery disease. This report is built using data and information sourced from secondary sources and primary research interviews and survey with leading Interventional Cardiologists and Interventional Radiologists, with in-house analysis conducted by Our team of industry experts.

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Disease Overview

4 Competitive Assessment

5 Unmet Needs

6 Pipeline Products

7 Clinical Trial Analysis

8 Industry Overview

9 Current and Future Players

10 Market Drivers, Opportunities, Barriers and Substitutes

11 Drug-Eluting Balloon Market Analysis

12 Country Outlooks & Forecasts

13 Appendix

Companies Mentioned

  • Aachen Resonance
  • AnGes MG
  • AngioScore
  • AVIDAL Vascular
  • B. Braun
  • Biosensors International
  • Biotronik
  • Blue Medical
  • Boston Scientific Corporation
  • Caliber Therapeutics
  • Cardionovum
  • Concept Medical Research
  • Cook Medical
  • Covidien
  • C.R. Bard
  • Elixir Medical Corporation
  • Eurocor
  • LifeTech Scientific Corporation
  • Medtronic
  • Micell Technologies
  • Minvasys
  • TriReme Medical
  • Vascular Nanotransfer Technologies

For more information visit http://www.researchandmarkets.com/research/69hmld/medipoint

Contact:
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Devices

Market Data

  • Currencies
    Currencies
    NamePriceChange% Chg
    0.9285-0.008-0.85%
    AUDUSD=X
    0.5528-0.0038-0.69%
    AUDGBP=X
    0.6709-0.0075-1.11%
    AUDEUR=X
  • Commodities
    Commodities
    NamePriceChange% Chg